A clinical study collected serum samples from 12 untreated patients with Parkinson’s disease (aged 63–78 years) and detected a significantly upregulated expression of NLRP3 inflammasome, caspase-1, and IL-1β levels [87]. Here, NLRP3 is linked to Parkinson disease.